New IPR Policy for Academic Institutions on the anvil

“The patent system added the fuel of interest to the fire of genius, in the discovery and production of new and useful things.”-Abraham Lincoln. No one can refute the words of Abraham Lincoln more so today, as we live in the knowledge era. Therefore, it has become imperative to enhance creativity, innovation and competitiveness by harnessing the IP of individuals, institutions, industry and the […]

Government of India initiative to boost Intellectual Property Rights

To nurture innovation and creativity in a knowledge economy, Indian Government has reduced the official fees for filing of patent application, requesting for normal or expedited examination and for renewing the granted patents to the tune of 60 to 68 percent especially for MSMEs who play a key role in the economic growth of India. The fee reduction has also […]

Burden of Proof in case of Process Patent

Judgement Date: Aug 14, 2019 Shogun Organics Limited (the plaintiff), has filed the present suit seeking a permanent injunction restraining infringement of its Patent IN-236630 (IN‘630) against Defendants (Solex Chemicals Pvt. Ltd, Director of the Solex, Orachem Pvt. Ltd (Trading partner of Solex), Manaksia Ltd, and  Endura SPA. The IN’630 patent relates to a “Process for manufacturing D-trans Allethrin”. Allethrin […]

Hindustan Zinc receives its first European patent

The patent EP3192882 granted in July 31, 2019 discloses method of production of Potassium Antimony Tartrate (PAT) by utlizing waste products bearing antimony. Potassium Antimony Tartrate (PAT) is consumed by Zinc hydro smelters for purification of Zinc Sulphate solution to produce Zinc metal. The USA and India equivalents of this patent are under processing. The patented process has been commercialized and is running successfully at […]

Patent infringement actions are maintainable only in respect of granted and live patents

On Aug. 20, 2019, High Court of Delhi Passed order that “Patent infringement actions are maintainable only in respect of granted and live patents.” Plaintiff: Novartis AG & ANR.      . Defendant: Natco Pharma Ltd. The suit concerns the Plaintiff’s patent number IN 276026 titled ‘Novel Pyrimidine Compounds and Compositions as Protein Kinase Inhibitors” relating Ceritinib drug for treating non-small cell […]